Sophie Gerritse is PhD student medical oncology. After completing her medical school at the ‘Vrije Universiteit Amsterdam’ she started in 2013 as a resident ‘Internal Medicine’ in the Rotterdam Region (Amphia Ziekenhuis Breda, Sint Fransiscus Rotterdam). Aiming to become a medical oncologist and with the current significant advances in basic and applied cancer research, she decided to pause her residency program to attend a full-time PhD-program within the medical oncology under the supervision of prof. dr. H.M.W. Verheul (Amsterdam-UMC, location VUmc and Radboud UMC Nijmegen). She is the study coordinator of several (Phase I, II) clinical studies with the main focus to optimize therapy with targeted agents in metastatic (colorectal) cancer. She has experience in the design, set-up and management of clinical trials and translation of pre-clinical results. She is currently continuing her residency in the Erasmus Medical Center in Rotterdam, aiming to become a medical oncologist and clinical pharmacologist.